Could Latin America be pharma’s next big success story? With growth rates outshining Europe and the US, the region is full of untapped potential — and it might just surprise you.

On World MS Day 2025, we take a closer look at the evolving multiple sclerosis pipeline and competitive landscape.

With nearly 60 agents in development, the field is advancing — but where is innovation truly happening, and where are gaps still evident? Our analysis offers strategic insights into emerging mechanisms, development phases, and subtype focus across RRMS, SPMS, and PPMS.